{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:23Z","timestamp":1786998323539,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007927","name":"University of Oklahoma Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008271","name":"College of Medicine, University of Oklahoma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.xfre.2020.09.015","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:24:43Z","timestamp":1602145483000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated activity levels of activating autoantibodies to the GnRH receptor in patients with polycystic ovary syndrome"],"prefix":"10.1016","volume":"1","author":[{"given":"Elizabeth A.","family":"Weedin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Burks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Aston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaTasha B.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2020.09.015_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2020.09.015_bib2","first-page":"9","article-title":"Polycystic ovary syndrome and its impact on women\u2019s quality of life: more than just an endocrine disorder","volume":"1","author":"Brady","year":"2009","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.xfre.2020.09.015_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.09.015_bib4","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2020.09.015_bib5","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2020.09.015_bib6","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xfre.2020.09.015_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.09.015_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/db09-1048","article-title":"Gene variants in the novel type 2 diabetes loci CDC123\/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function","volume":"59","author":"Simonis-Bik","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.xfre.2020.09.015_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-m\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.xfre.2020.09.015_bib10","series-title":"Clinical Gynecologic Endocrinology and Infertility","author":"Speroff","year":"2005"},{"key":"10.1016\/j.xfre.2020.09.015_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI0215745","article-title":"Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor","volume":"110","author":"Chazenbalk","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.xfre.2020.09.015_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.xfre.2020.09.015_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa078","article-title":"The role of GnRH receptor autoantibodies in polycystic ovary syndrome","volume":"4","author":"Kem","year":"2020","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.xfre.2020.09.015_bib14","article-title":"The effect of GNRHR autoantibody on reproduction function and insulin signaling intermediates in a new animal model of polycystic ovary syndrome","volume":"4","author":"Li","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.xfre.2020.09.015_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","article-title":"The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial","volume":"101","author":"Legro","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2020.09.015_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334120300866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334120300866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:03:30Z","timestamp":1762981410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334120300866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2666334120300866"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2020.09.015","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated activity levels of activating autoantibodies to the GnRH receptor in patients with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2020.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}